Steven C. Quay - Feb 24, 2022 Form 4 Insider Report for ATOSSA THERAPEUTICS, INC. (ATOS)

Role
President & CEO, Director
Signature
/s/ Steven Quay
Stock symbol
ATOS
Transactions as of
Feb 24, 2022
Transactions value $
$0
Form type
4
Date filed
2/28/2022, 04:15 PM
Previous filing
May 18, 2021
Next filing
Mar 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATOS Stock Option (right to buy) Award $0 +1.9M $0.00 1.9M Feb 24, 2022 Common Stock 1.9M $1.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest on a quarterly basis over two (2) years.